When combining peptides, it is advisable to start with conservative doses of each compound and gradually adjust based on individual response and tolerance
The primary antibodies were anti-GPX1 (1:1,000 dilution, GeneTex, GTX116040), anti-C-caspase 3 (1:500 dilution, Cell Signaling Technology, 9664), anti-4-HNE (1:1000, Abcam, ab46545), anti-phosphorylated (p)-NFB p65 (1:1,000 dilution, Cell Signaling Technology, 3033), and anti--actin (1:2,000 dilution, ZSGB-BIO, TA-09)
It can also be used as a conductive medium if compatible with your specific device protocols
Participants will receive semaglutide s.c.and placebo matched to cagrilintide once-weekly after a dose escalation period of 16 weeks during the maintenance period for 52 weeks